Phytochemical Modulation of the Kynurenine Pathway (KYNP) and Its Emerging Mechanistic Insights into Cancer Progression: A Systematic Review
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27177512 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Evgenia Maria Tsantila und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, European University Cyprus, Nicosia 2404, Cyprus. Hauptthemen laut MEDLINE: Kynurenine, Neoplasms, Phytochemicals. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alpinamed AG, European University of Cyprus.
Abstract (Originalsprache)
Dysregulation of the kynurenine pathway (KYNP) is increasingly recognized as a hallmark of cancer-associated metabolic reprogramming, contributing to immune evasion, oxidative stress, and tumor progression through the activity of enzymes such as indoleamine 2,3-dioxygenase 1 (IDO1), indoleamine 2,3-dioxygenase 2 (IDO2), and tryptophan 2,3-dioxygenase (TDO2). This systematic review aimed to evaluate the current evidence on the ability of phytochemicals to modulate the KYNP and their potential implications for cancer prevention and therapy. The review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and included English-language articles and book chapters published between 2016 and 2026 that were retrieved from the Scopus and PubMed databases. A keyword co-occurrence network was generated using VOSviewer (v1.6.20) based on the complete Scopus and PubMed exports of the included studies to identify major research themes. The available evidence indicates that phytochemicals restore anticancer immunity by targeting multiple components of the KYNP, including inhibition of IDO1-mediated kynurenine production and suppression of downstream aryl hydrocarbon receptor signalling, thereby enhancing cytotoxic T-cell responses, reducing immunosuppressive cell populations, and improving antitumor immune activity. Collectively, these findings support the KYNP as a promising immunometabolic target and highlight phytochemicals as potential complementary agents for cancer immunotherapy while emphasizing the need for further investigation of the biological and immunological roles of IDO2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Life Sciences, European University Cyprus, Nicosia 2404, Cyprus.
- Department of Research and Development, Alpinamed AG, 9306 Freidorf, Switzerland.
ORCID-Profile: Evgenia Maria Tsantila, Marios C Christodoulou, Christiana M Neophytou
Förderung
- Alpinamed AG
- European University of Cyprus
Zitieren
APA
Tsantila, E. M., Christodoulou, M. C., Esslinger, N., & Neophytou, C. M. (2026). Phytochemical Modulation of the Kynurenine Pathway (KYNP) and Its Emerging Mechanistic Insights into Cancer Progression: A Systematic Review. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27177512
Vancouver
Tsantila EM, Christodoulou MC, Esslinger N, Neophytou CM. Phytochemical Modulation of the Kynurenine Pathway (KYNP) and Its Emerging Mechanistic Insights into Cancer Progression: A Systematic Review. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27177512
BibTeX
@article{Tsantila2026,
author = {Tsantila, Evgenia Maria and Christodoulou, Marios C and Esslinger, Nils and Neophytou, Christiana M},
title = {Phytochemical Modulation of the Kynurenine Pathway (KYNP) and Its Emerging Mechanistic Insights into Cancer Progression: A Systematic Review},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27177512}
}
EUVIMED